{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:52:40Z","timestamp":1791161560542,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.neuropharm.2008.02.005","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T15:41:09Z","timestamp":1203522069000},"page":"976-988","source":"Crossref","is-referenced-by-count":35,"title":["CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats"],"prefix":"10.1016","volume":"54","author":[{"given":"Marina","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Maestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Michael Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.02.005_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Ar\u00e9valo","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib2","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1523\/JNEUROSCI.1768-04.2004","article-title":"Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors","volume":"24","author":"Ariwodola","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Pyschopharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02244208","article-title":"CRF antagonist reverses the \u201canxiogenic\u201d response to ethanol withdrawal in the rat","volume":"103","author":"Baldwin","year":"1991","journal-title":"Pyschopharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/0929867306666220401143808","article-title":"The development of cannabinoid antagonists","volume":"6","author":"Barth","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(98)01072-5","article-title":"Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP\u03b3S binding in synaptic plasma membrane from chronic ethanol exposed mouse","volume":"815","author":"Basavarajappa","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.1999.0720522.x","article-title":"Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells","volume":"72","author":"Basavarajappa","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0925-4439(00)00085-5","article-title":"Stimulation of cannabinoid receptor agonist 2-arachidonoylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons","volume":"1535","author":"Basavarajappa","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jnr.1094","article-title":"Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate-\u03b3-S binding in the brain of C57BL\/6 and DBA\/2 mice","volume":"64","author":"Basavarajappa","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(03)01557-7","article-title":"Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons","volume":"466","author":"Basavarajappa","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/alcalc\/agh111","article-title":"Role of the endocannabinoid system in the development of tolerance to alcohol","volume":"40","author":"Basavarajappa","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuropharm.2005.12.005","article-title":"Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice","volume":"50","author":"Basavarajappa","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib13","first-page":"105","article-title":"Animal models of alcohol withdrawal","volume":"24","author":"Becker","year":"2000","journal-title":"Alcohol. Res. Health"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-side effects induced by \u03949-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0091-3057(02)00958-9","article-title":"Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze","volume":"73","author":"Bertoglio","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib16","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.npp.1301274","article-title":"Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase","volume":"32","author":"Blednov","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0278-5846(01)00234-2","article-title":"Treatment of alcohol withdrawal with gabapentin","volume":"26","author":"Bozikas","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/oxfordjournals.alcalc.a008368","article-title":"Reduction of voluntary ethanol intake in ethanol preferring SP by the cannabinoid antagonist SR141716","volume":"33","author":"Colombo","year":"1998","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2004.07.069","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats","volume":"498","author":"Colombo","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pbb.2005.01.022","article-title":"Endocannabinoid system and alcohol addiction: pharmacological studies","volume":"81","author":"Colombo","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.2004.02394.x","article-title":"Neuropeptides: implications for alcoholism","volume":"89","author":"Cowen","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/187152706776359646","article-title":"Alcoholism and neuropeptides: an update","volume":"5","author":"Cowen","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.ALC.0000056617.68874.18","article-title":"Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods","volume":"27","author":"Dahchour","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(03)00030-7","article-title":"Alcohol and withdrawal: from animal research to clinical issues","volume":"27","author":"De Witte","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.addbeh.2004.06.020","article-title":"Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol","volume":"29","author":"De Witte","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.ALC.0000057121.36127.19","article-title":"Enduring effects of chronic ethanol in the CNS: basis for alcoholism","volume":"27","author":"Diana","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0197-0186(00)00061-9","article-title":"Glutamate-mediated transmission, alcohol, and alcoholism","volume":"37","author":"Dodd","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0301-0082(98)00032-X","article-title":"Chronic ethanol consumption: from neuroadaptation to neurodegeneration","volume":"56","author":"Fadda","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BJ20061898","article-title":"Regulation of brain anandamide by acute administration of ethanol","volume":"404","author":"Ferrer","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-0173(02)00218-7","article-title":"Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, \u2018entourage\u2019 compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects","volume":"41","author":"Fowler","year":"2003","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1530-0277.2001.tb02209.x","article-title":"Effects of SR141716A on ethanol and sucrose self-administration","volume":"25","author":"Freedland","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.devbrainres.2005.03.005","article-title":"Postnatal handling does not normalize hypothalamic corticotropin-releasing factor mRNA levels in animals prenatally exposed to ethanol","volume":"157","author":"Gabriel","year":"2005","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-002-1291-z","article-title":"The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety","volume":"166","author":"Gallate","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0024-3205(99)00251-9","article-title":"Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide","volume":"65","author":"Gonz\u00e1lez","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00186-7","article-title":"Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels","volume":"66","author":"Gonz\u00e1lez","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonz\u00e1lez","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjp.0705963","article-title":"Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse","volume":"143","author":"Gonz\u00e1lez","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-3084(00)00192-4","article-title":"N-Acylethanolamines and precursor phospholipids \u2013 relation to cell injury","volume":"108","author":"Hansen","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.103.052092","article-title":"Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation","volume":"311","author":"Heinrichs","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in situ autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib45","first-page":"41","article-title":"Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats","volume":"9","author":"Holter","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-4547(20000401)60:1<122::AID-JNR13>3.0.CO;2-S","article-title":"Distinct differences in the cannabinoid receptor binding in the brain of C57BL\/6 and DBA\/2 mice, selected for their differences in voluntary ethanol consumption","volume":"60","author":"Hungund","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1530-0277.2002.tb02575.x","article-title":"Ethanol, endocannabinoids, and the cannabinoidergic signaling system","volume":"26","author":"Hungund","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib48","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","article-title":"Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens","volume":"84","author":"Hungund","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/alcalc\/agg095","article-title":"Alcohol intake after serotonin transporter inactivation in mice","volume":"38","author":"Kelai","year":"2003","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib50","doi-asserted-by":"crossref","first-page":"17287","DOI":"10.1074\/jbc.271.29.17287","article-title":"Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue","volume":"271","author":"Kempe","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09652140050111663","article-title":"Animal models of craving for ethanol","volume":"95","author":"Koob","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","article-title":"Alcoholism: allostasis and beyond","volume":"27","author":"Koob","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib53","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.bcp.2004.07.031","article-title":"A role for GABA mechanisms in the motivational effects of alcohol","volume":"68","author":"Koob","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib54","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1530-0277.2001.tb02353.x","article-title":"Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration","volume":"25","author":"Lallemand","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/alcalc\/agh115","article-title":"Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference","volume":"40","author":"Lallemand","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00200-0","article-title":"Neurobiology of relapse to alcohol in rats","volume":"94","author":"L\u00ea","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib58","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1007\/BF02854900","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1615\/CritRevNeurobiol.v12.i4.40","article-title":"Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents","volume":"12","author":"McBride","year":"1998","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib62","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1530-0277.2007.00366.x","article-title":"Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence","volume":"31","author":"Mitrirattanakul","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib63","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2174\/0929867054020891","article-title":"Current knowledge on the antagonists and inverse agonists of cannabinoid receptors","volume":"12","author":"Muccioli","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2003.09.002","article-title":"Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice","volume":"46","author":"Naassila","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","volume":"8","author":"Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/alcalc\/agh063","article-title":"Differences in basal cannabinoid CB1 receptor function in selective brain areas and vulnerability to voluntary alcohol consumption in Fawn Hooded and Wistar rats","volume":"39","author":"Ortiz","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/alcalc\/agh036","article-title":"Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain","volume":"39","author":"Ortiz","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib68","series-title":"Maps and Guide to Microdissection of the Rat Brain","author":"Palkovits","year":"1988"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib69","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/156800705774933014","article-title":"Endocannabinoids and drug dependence","volume":"4","author":"Parolaro","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib70","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(01)00130-9","article-title":"The endocannabinoid nervous system: unique opportunities for therapeutic intervention","volume":"90","author":"Porter","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib73","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.mp.4001278","article-title":"Association between cannabinoid receptor gene (CNR1) and childhood attention deficit\/hyperactivity disorder in Spanish male alcoholic patients","volume":"8","author":"Ponce","year":"2003","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib74","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.23-06-02453.2003","article-title":"A critical role for the cannabinoid-CB1 receptor in alcohol dependence and stress-stimulated alcohol drinking","volume":"23","author":"Racz","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1530-0277.2001.tb02308.x","article-title":"Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence","volume":"25","author":"Rasmussen","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib76","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1460-9568.2003.02548.x","article-title":"\u2018One-trial sensitization\u2019 to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze","volume":"17","author":"Rodgers","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(95)00344-K","article-title":"Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum","volume":"283","author":"Rossetti","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib78","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2007.05.052","article-title":"Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol","volume":"421","author":"Rubio","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00210-005-0026-1","article-title":"Chronic \u03949-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex","volume":"372","author":"Sagredo","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0031-6997(24)01492-3","article-title":"The role of corticotropin-releasing factor in drug addiction","volume":"53","author":"Sarnyai","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","article-title":"Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence","volume":"65","author":"Schmidt","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib82","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/01.ALC.0000098873.80433.BA","article-title":"Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration","volume":"27","author":"Schroeder","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0014-2999(01)01379-6","article-title":"The cannabinoid receptor antagonist SR141716 prevents acquisition of drinking behavior in alcohol-preferring rats","volume":"430","author":"Serra","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(02)01594-7","article-title":"Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats","volume":"443","author":"Serra","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib84","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib85","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0378-4347(93)E0391-3","article-title":"Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection","volume":"652","author":"Smith","year":"1994","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib86","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brainres.2004.04.037","article-title":"Reduced neuropeptide Y mRNA expression in the central nucleus of amygdala of alcohol preferring (P) rats: its potential involvement in alcohol preference and anxiety","volume":"1014","author":"Suzuki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib87","series-title":"Cannabinoids","first-page":"327","article-title":"Effects of cannabinoids on neurotransmission","volume":"vol. 168","author":"Szabo","year":"2005"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.49.1.173","article-title":"The role of glutamatergic neurotransmission in the pathophysiology of alcoholism","volume":"49","author":"Tsai","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib89","first-page":"1","article-title":"Molecular neurobiological methods in marijuana-cannabinoid research","volume":"123","author":"Uhl","year":"2006","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0741-8329(03)00020-X","article-title":"Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to\u00a0stress observed during protracted ethanol abstinence","volume":"29","author":"Valdez","year":"2003","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2008.02.005_bib91","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.pbb.2004.09.020","article-title":"Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism","volume":"79","author":"Valdez","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib92","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuint.2006.05.002","article-title":"Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system","volume":"49","author":"Vinod","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib93","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","article-title":"Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib94","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1523\/JNEUROSCI.22-09-03332.2002","article-title":"Behavioral neurobiology of alcohol addiction: recent advances and challenges","volume":"22","author":"Weiss","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.02.005_bib95","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1073\/pnas.83.24.9827","article-title":"Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain","volume":"83","author":"Young","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:11:41Z","timestamp":1738084301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0028390808000464"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.02.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}